Video Description:
The video opens on an animated title slide featuring the title “Zantac 360°® Video presentation by Dr. Jeffrey Nathanson” with the Zantac 360° logo.
The video transitions to Dr. Jeffrey Nathanson, who discusses how Zantac 360° works and the benefits to patients. His key talking points appear onscreen.
There is light music in the background as he speaks.
Audio:
Hello! I’m Dr. Jeffrey Nathanson.
In this video presentation, we’re going to discuss Zantac 360°, formulated with FDA-approved famotidine, for patients who need flexible, safe, and effective prevention or relief of heartburn, fast.
Zantac 360° is formulated with famotidine, the #1 doctor recommended over-the-counter H2 blocker.
Famotidine is a highly selective and long-acting H2-receptor antagonist that prevents heartburn when taken as little as 15 minutes before eating or drinking and relieves heartburn fast1. Famotidine works by selectively targeting and blocking H2 receptors on parietal cells in the stomach to decrease gastric acid production2-4.
Available in Original 10 milligram and Maximum 20 milligram, Zantac 360° can be taken before or after the onset of heartburn symptoms, empowering your patients to control their heartburn when they need to.
Clinical studies have shown that famotidine, the active ingredient in Zantac 360°, can control stomach acid for up to 12 hours. Studies have also shown that famotidine 10 milligrams (the dosage in Zantac 360°Original Strength), and 20 milligrams (the dosage in Zantac 360° Maximum Strength) can act fast, with significantly more patients reporting complete relief of heartburn within 1 hour compared with placebo.
There are 3 over-the-counter classes of medicine for heartburn: H2 receptor antagonists such as Zantac 360°, proton pump inhibitors (or PPIs), and antacids.
All of these work differently, and – importantly – only H2 receptor antagonists are indicated to both prevent and relieve heartburn.
Antacids act rapidly to neutralize stomach acid but have a short duration and cannot prevent heartburn.
PPIs inhibit the gastric proton pump to control stomach acid, but they are not intended for immediate relief (and according to product’s directions, may take 1 to 4 days for full effect).
Now that we’ve discussed how Zantac 360° works, let’s move on to some frequently asked questions.
First, is it safe for patients to use Zantac 360° on a daily basis?
Adults and children 12 years and over may take up to two Zantac 360° tablets in a 24-hour period to prevent or relieve symptoms. If the symptoms persist for more than 14 days, or worsen, patients should stop use and talk to their doctor.
When should patients take Zantac 360°?
Zantac 360° Original Strength can be taken 15 to 60 minutes before eating food or drinking beverages that may cause heartburn in order to prevent symptoms, or it can be taken when heartburn symptoms strike, for fast, long-lasting acid control for up to 12 hours.
Zantac 360° Maximum Strength can be taken 10 to 60 minutes before eating food or drinking beverages that may cause heartburn in order to prevent symptoms, or it can be taken when heartburn symptoms strike, for fast, long-lasting acid control for up to 12 hours.
How does Zantac 360° work?
Famotidine, the active ingredient in Zantac 360°, works by selectively targeting and blocking H2 receptors on parietal cells in the stomach to decrease gastric acid production.
In summary, Zantac 360° is formulated with famotidine, a clinically proven H2 receptor antagonist, which is FDA approved as safe and effective to both prevent and relieve heartburn fast, with just one pill.
Available in two strengths, and offering flexible over-the-counter control, recommend Zantac 360° for the short-term management of occasional heartburn.
I appreciate you listening to this important information today. I hope you find it useful.
Still have questions regarding Zantac 360°? For additional questions regarding Zantac 360° please submit your questions online or call 1-800-633-1610.
Video Description:
Video transitions to website, then ends on footnote references listed below:
References
- Lopez, He, and Korvick. (2002) Medical Officer’s Clinical Efficacy Review. NDA 20-325/S-015. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020325_S015_PEPCID%20AC%20TABLETS_BIOPHARMR.pdf
- Ryan, et al (1986) Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretion. The American Journal of Medicine. Vol 81: 60-84
- Smith (1986) Clinical Pharmacology of Famotidine. Digestion. Vol 32: 15-23
- Konturek, et al (2007) The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial. Med Sci Monit. Vol 13(1): CR44-49